Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
UroGen Pharma Stock: An Emerging GARP Stock (NASDAQ:URGN)
UroGen Pharma has pulled back 30% after a 208% rally, driven by Zusduri's strong launch as the only approved non-surgical LG-IR-NMIBC therapy. Zusduri's rapid uptake, favorable patient preference, and robust clinical data support continued growth…
Sun Pharma board approves plan to raise up to ₹10,000 cr via NCDs
Sun Pharmaceutical Industries has said its board of directors has approved a proposal to raise funds of up to ₹10,000 crore through the issuance of non-convertible debentures (NCDs). The decision was taken at a meeting of the company's Board…
Pharmalittle: We're reading about concerns over a rare disease drug, pharma payments to docs, and more
Rise and shine, everyone, another busy day is on the way. And it is getting off to a pleasant start here on the Pharmalot campus, where clear blue skies and comfy breezes are greeting us. As for the official mascots, they are happily snoozing in…
Nuvectis Pharma (NASDAQ:NVCT) Shares Gap Up - What's Next?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s stock price gapped up prior to trading on Monday. The stock had previously closed at $20.13, but opened at $21.12. Nuvectis Pharma shares last traded at $21.20, with a volume of 1,499 shares…
India Contract Drugmaker Piramal Says Focused on Cutting China Exposure
Indian contract drug manufacturer Piramal Pharma Ltd. has cut its exposure to Chinese raw materials in a bid to reduce concentration risk, as countries globally look to diversify critical drug supply chains. “One of the things that we worked…
Virtu Financial: A Buy The Dip Moment For Market Maker With Proven Durability (NYSE:VIRT)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
100,000 signatures oppose Swiss government rent proposal
The association has handed over a petition with 100,848 signatures, to the Federal Chancellery. The signatories are calling for an immediate halt to the drafting of an indirect counter-proposal to the rent initiative. The draft currently being…
HK's SFC cracks down on suspected IPO-rigging syndicates with $4.6b frozen after ChaPanda trading halt
Hong Kong's securities watchdog has cracked down on two suspected initial public offering-rigging syndicates, freezing over HK$4.6 billion in assets across 35 brokerages, after halting trading in bubble tea chain Sichuan Baicha Baidao Industrial…
Drug-Eluting Intraocular Lens Passes Test in Patients With Cataracts and Glaucoma
NEW ORLEANS -- An intraocular lens (IOL) packed with glaucoma medication showed early promise as a potential treatment for cataract and glaucoma in randomized comparison against standard glaucoma therapy. The bimatoprost drug pad-intraocular lens…
Generate Biomedicines: The Dosing Interval Is The Moat, Not The Algorithm (NASDAQ:GENB)
Generate Biomedicines offers a compelling long-acting asthma biologic, golukibart (GB-0895), targeting twice-yearly dosing and broad phenotype efficacy. GENB leads the TSLP antagonist race with two global Phase 3 trials underway, aiming to displace…
Nordic American Tankers: Grab That 13% Yield While The Tanker Boom Lasts (NYSE:NAT)
Nordic American Tankers is rated Buy, driven by surging tanker rates, strong recent fixtures, and an attractive—though variable—dividend yield near 13%. Recent fixtures averaged $96,800/day, far above Q2's $63,000/day, but…
Agilisium eyes topline of $0.5 billion in 5-7 years
Agilisium, a life science-focused technology services firm has set itself a target of $0.5 billion in revenues by the next five to seven years. The ambitious topline target comes at a time when the company, which has a large presence in Chennai…
Top Healthcare Stocks: Playing Offense And Defense For The Win
Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by…
Wynn Resorts Is A Buy As Global Hotel/Casino Portfolio Shows Resilience (NASDAQ:WYNN)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Eli Lilly Expects Up to $87 Billion in 2026 Revenue. Here's Why the Stock Still Looks Undervalued.
Eli Lilly (LLY +0.28%) stock has soared 400% over the past five years, and though the momentum slowed in the early months of this year, it's now on the rise again. The stock has advanced 25% over the past six months, buoyed by optimism about…
Receive a Daily briefing on Pharma Industry News
Get Started